Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells

CD11b+Gr1+ myeloid-derived suppressor cells (MDSCs) suppress activation/proliferation of cytotoxic T cells, thereby hindering cancer immunotherapy. MDSCs are increased after adjuvant therapy with toll-like receptor (TLR) 2 ligands, such as Pam2CSK4, in tumor-bearing mice. However, it remains unknown...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hiroaki Shime, Akira Maruyama, Sumito Yoshida, Yohei Takeda, Misako Matsumoto, Tsukasa Seya
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis Group 2018-01-01
Edice:OncoImmunology
Témata:
inducible no synthase (inos/nos2)
interferon-γ (ifn-γ)
macrophages
monocytic mdscs (m-mdscs)
myeloid-derived suppressor cells (mdscs)
nitric oxide (no)
toll-like receptor 2 (tlr2)
On-line přístup:http://dx.doi.org/10.1080/2162402X.2017.1373231
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky